Cornell Tech is a technology, business, law, and design campus of Cornell University located on Roosevelt Island in Manhattan, New York City. It includes the Jacobs Technion-Cornell Institute, a joint academic venture between Cornell and the Technion – Israel Institute of Technology.

During the past decade, Cornell University conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 26 clinical trials were completed, i.e. on average, 83.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cornell University" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 23 trials, followed by "Edwards Lifesciences" with 8 trials sponsored, "Celgene" with 4 trials sponsored, "Seagen Inc." with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cornell University" #1 collaborator was "Glaxo Wellcome" with 5 trials as a collaborator, "Cornell University" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 61 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "Cornell University" are "HIV Infections" (22 trials), "Crohn Disease" (5 trials), "Aortic Stenosis" (4 trials), "Pulmonary Arterial Hypertension" (3 trials) and "Aortic Stenosis, Severe" (2 trials). Many other conditions were trialed in "Cornell University" in a lesser frequency.

Most popular intervention types in "Cornell University" are "Drug" (60 trials), "Device" (14 trials), "Other" (8 trials), "Procedure" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (6 trials), "Didanosine" (4 trials), "Placebo" (4 trials), "Itraconazole" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Cornell University" are 89 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Cornell University". 1 are not yet recruiting, 13 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 68 completed trials in Cornell University, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Cornell University, 17 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 21 trials that are defined as “Not Applicable".